185 related articles for article (PubMed ID: 35218073)
21. A rare case of subcutaneous phaeohyphomycosis caused by a Rhytidhysteron species: a clinico-therapeutic experience.
Mahajan VK; Sharma V; Prabha N; Thakur K; Sharma NL; Rudramurthy SM; Chauhan PS; Mehta KS; Abhinav C
Int J Dermatol; 2014 Dec; 53(12):1485-9. PubMed ID: 24898242
[TBL] [Abstract][Full Text] [Related]
22. Subcutaneous phaeohyphomycosis caused by Exophiala jeanselmei: successful treatment with itraconazole.
Chuan MT; Wu MC
Int J Dermatol; 1995 Aug; 34(8):563-6. PubMed ID: 7591439
[No Abstract] [Full Text] [Related]
23. Disseminated subcutaneous phaeohyphomycosis caused by Exophiala oligosperma in a patient with Wegener's granulomatosis.
Kan T; Takahagi S; Kamegashira A; Ooiwa H; Yaguchi T; Hide M
Acta Derm Venereol; 2013 May; 93(3):356-7. PubMed ID: 22983069
[No Abstract] [Full Text] [Related]
24. Recurrent cutaneous Exophiala phaeohyphomycosis in an immunosuppressed patient.
Turner N; Kibbi N; Panse G; Imaeda S
Cutis; 2020 Nov; 106(5):E7-E8. PubMed ID: 33465199
[No Abstract] [Full Text] [Related]
25. Exophiala dermatitidis pneumonia successfully treated with long-term itraconazole therapy.
Mukai Y; Nureki S; Hata M; Shigenaga T; Tokimatsu I; Miyazaki E; Kadota J; Yarita K; Kamei K
J Infect Chemother; 2014 Jul; 20(7):446-9. PubMed ID: 24767462
[TBL] [Abstract][Full Text] [Related]
26. Review of the alternative therapies for onychomycosis and superficial fungal infections: posaconazole, fosravuconazole, voriconazole, oteseconazole.
Gupta AK; Talukder M; Venkataraman M
Int J Dermatol; 2022 Dec; 61(12):1431-1441. PubMed ID: 34882787
[TBL] [Abstract][Full Text] [Related]
27. Antifungal activity of antifungal drugs, as well as drug combinations against Exophiala dermatitidis.
Sun Y; Liu W; Wan Z; Wang X; Li R
Mycopathologia; 2011 Feb; 171(2):111-7. PubMed ID: 20803255
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous phaeohyphomycosis caused by Exophiala spinifera in a patient with systemic lupus erythematosus.
Lin YP; Li W; Yang YP; Huang WM; Fan YM
Lupus; 2012 Apr; 21(5):548-51. PubMed ID: 22065094
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous and mucosal phaeohyphomycosis caused by Exophiala spinifera in a pregnant patient: case report and literature review.
Wang L; She X; Lv G; Shen Y; Cai Q; Zeng R; Li C; Ge Y; Deng S; de Hoog GS; Li M; Liu W
Mycopathologia; 2013 Apr; 175(3-4):331-8. PubMed ID: 23334555
[TBL] [Abstract][Full Text] [Related]
30. Exophiala dermatitidis as a cause of central line associated bloodstream infection in an infant: Case report and literature review.
Kumar A; Nandakumar A; Nair S; Singh A; Shashindran N; Thulasidharan S; Subhash K; Ramachandran A; Chowdhary A
Rev Iberoam Micol; 2021; 38(1):12-15. PubMed ID: 33279387
[TBL] [Abstract][Full Text] [Related]
31. Phaeohyphomycosis due to Exophiala spinifera greatly improved by ALA-PDT: A case report.
Liu H; Zhang J; Chen Y; Xue R; Zeng W; Xi L; Chen Y
Photodiagnosis Photodyn Ther; 2019 Dec; 28():297-299. PubMed ID: 31606515
[TBL] [Abstract][Full Text] [Related]
32.
Sun Y; Tan L; Yao Z; Gao L; Yang J; Zeng T
Microbiol Spectr; 2022 Feb; 10(1):e0200721. PubMed ID: 35019705
[TBL] [Abstract][Full Text] [Related]
33. A Case of Recalcitrant Phaeohyphomycosis of the Face Caused by Exophiala lecanii-corni.
Hatta J; Anzawa K; Kubota K; Ohtani T; Mochizuki T
Med Mycol J; 2021; 62(2):35-39. PubMed ID: 34053978
[TBL] [Abstract][Full Text] [Related]
34. Morphological and Molecular Characterization of Exophiala polymorpha sp. nov. Isolated from Sporotrichoid Lymphocutaneous Lesions in a Patient with Myasthenia Gravis.
Yong LK; Wiederhold NP; Sutton DA; Sandoval-Denis M; Lindner JR; Fan H; Sanders C; Guarro J
J Clin Microbiol; 2015 Sep; 53(9):2816-22. PubMed ID: 26085612
[TBL] [Abstract][Full Text] [Related]
35. The first case of phaeohyphomycosis caused by Rhinocladiella basitona in an immunocompetent child in China.
Cai Q; Lv GX; Jiang YQ; Mei H; Hu SQ; Xu HB; Wu XF; Shen YN; Liu WD
Mycopathologia; 2013 Aug; 176(1-2):101-5. PubMed ID: 23591621
[TBL] [Abstract][Full Text] [Related]
36. Subcutaneous phaeohyphomycosis caused by Exophiala oligosperma in a renal transplant recipient.
González-López MA; Salesa R; González-Vela MC; Fernández-Llaca H; Val-Bernal JF; Cano J
Br J Dermatol; 2007 Apr; 156(4):762-4. PubMed ID: 17263805
[No Abstract] [Full Text] [Related]
37. Exophiala deep fungal infection complicating dermatitis artefacta of the arms responding to itraconazole.
Martanto W; Tee SI; Pan JY
J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1262-3. PubMed ID: 24330382
[No Abstract] [Full Text] [Related]
38. Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis.
Gupta AK; Talukder M; Shemer A; Galili E
Expert Rev Anti Infect Ther; 2024 Jun; 22(6):399-412. PubMed ID: 38841996
[TBL] [Abstract][Full Text] [Related]
39. Doubly Misdiagnosed: Exophiala Masquerading as Squamous Cell Carcinoma and Chromoblastomycosis.
Guerra R; Guffey D; Russell M
Am J Dermatopathol; 2022 Jan; 44(1):e8-e10. PubMed ID: 34086642
[TBL] [Abstract][Full Text] [Related]
40. New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole.
Coelho RA; Alves GM; Figueiredo-Carvalho MHG; Almeida-Silva F; de Souza GR; Lourenço MCDS; Brito-Santos F; Amaral ACF; Almeida-Paes R
Mem Inst Oswaldo Cruz; 2022; 117():e220089. PubMed ID: 36102413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
